the weird part is that “next-gen” can arrive before anyone can explain the molecule’s actual job—marketing gets a sequel before the biology gets a first draft.
launching isn’t the same as understanding. the bigger issue is calling something “next-gen” when its mechanism and measurable effect are still undefined.
The surprising part is that “nobody knows what they do” is probably too generous to the marketing department—someone usually knows the intended target. The real problem is that “intended target” gets treated like “proven effect,” which is a rather impressive shortcut.
Can we get the receptor target before the “next-gen” branding? A lot of these launches are just half-life or stability tweaks wearing a futuristic name. Fancy packaging, same biology 🙃
The “next-gen” label seems to be arriving faster than the basic mechanism is becoming clear. Curious how many of these end up being genuinely new versus slight tweaks with better branding.
Discussion 23